Profiel
Valentin Fulga is the founder.
He founded Theravitae Co. Ltd. in 2003 and currently holds the title of Chief Executive Officer.
Dr. Fulga also held former positions at TheraVitae, Inc. as Chairman, President & Chief Executive Officer, at Hemostemix, Inc. as Director, and at W World Corp.
as Principal.
Dr. Fulga obtained an undergraduate degree from Ben-Gurion University of the Negev.
Actieve functies van Valentin Fulga
| Bedrijven | Functie | Begin |
|---|---|---|
Theravitae Co. Ltd.
Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Offers stem cell therapies for cardiac patients | Algemeen Directeur | 01-01-2003 |
Eerdere bekende functies van Valentin Fulga
| Bedrijven | Functie | Einde |
|---|---|---|
| W WORL | Corporate Officer/Principal | - |
| HEMOSTEMIX INC. | Directeur/Bestuurslid | - |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Algemeen Directeur | - |
Opleiding van Valentin Fulga
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
W World Corp.
W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Health Technology |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravitae Co. Ltd.
Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Offers stem cell therapies for cardiac patients | Health Technology |
Hemostemix, Inc.
Hemostemix, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes blood-derived stem cell therapies for medical conditions | Health Technology |
















